SCHEDULE 13G/A

Statement of Beneficial Ownership

Foghorn Therapeutics Inc. Filed 2026-05-15 Acc 0000921895-26-001393

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-10-05 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-15 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-05-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)